Ruxolitinib in ET: not all MPN are equal
- PMID: 29074591
- DOI: 10.1182/blood-2017-08-802165
Ruxolitinib in ET: not all MPN are equal
Comment on
-
Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide.Blood. 2017 Oct 26;130(17):1889-1897. doi: 10.1182/blood-2017-05-785790. Epub 2017 Aug 9. Blood. 2017. PMID: 29074595 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources

